Gleneagles Global Hospitals successfully concluded its first-ever Medical and Quality Symposium in Mumbai on 28 November.
The event brought together healthcare leaders from across our Gleneagles India network for two days of knowledge sharing, strategic planning and team building, marking a significant milestone in our journey towards healthcare excellence.
A key highlight was the initiation of the Joint Commission International (JCI) accreditation process for Gleneagles Mumbai Hospital, as a mark of our firm commitment to global standards in patient care and safety. The symposium has left our team energised and united, as we poise ourselves to tackle future challenges and set new benchmarks in healthcare.
Related Stories
Friends of Fortis Programme Highlights Robotic Knee Replacement Outcomes in Amritsar
Project Renaissance at Mount Elizabeth Hospital, Where Legacy Meets the Future of Care
Over a span of 1,095 days, Project Renaissance marked a significant chapter in the evolution of Mount Elizabeth Hospital, one of Singapore’s most established private healthcare institutions. Conceived as a strategic transformation rather than a conventional refurbishment, the initiative sought to position the hospital for the demands of a rapidly changing healthcare landscape.
IHH Healthcare North Asia Strengthens Integrated Care Through Strategic Partnership
2026 IHH Global Town Hall: Building a Future-ready Workforce
'Building a Future-ready Workforce' took centre stage at IHH Healthcare's 2026 Global Town Hall on 9 February, bringing colleagues together across 10 countries in a truly hybrid experience that underscored the group's commitment to future-proof healthcare.
IHH Malaysia Partners Libyan Government for Medical Referrals
IHH Healthcare Malaysia signed a Memorandum of Understanding (MOU) with The Government of Libya on 9 February, establishing a structured medical referral pathway for Libyan civil servants requiring specialist treatment at 18 hospitals across IHH’s Malaysian network.
Agilus Diagnostics Expands Access to Next-Generation Precision Genomics
Agilus Diagnostics, a subsidiary of Fortis Healthcare, has installed the Illumina NovaSeq X sequencing platform at its Mumbai reference laboratory, marking a major step forward for precision genomics in India.
